Navigation Links
Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update

30,397292,193Patent filing fees, net

807,357701,846Other assets

59,56875,394Total assets$
4,086,177LIABILITIES AND STOCKHOLDERS' EQUITYCURRENT LIABILITIESAccounts payable and accrued expenses 

,843,684Accrued bonus expense

465,865582,675Other current liabilities

90,776-Total current liabilities1,756,3032,426,359Deferred rent, net of current portion

21,143-Total liabilities

1,777,4462,426,359STOCKHOLDERS' EQUITYPreferred stock, 7,000,000 shares authorized, zero shares issued and outstanding

--Common stock, $0.01 par value; 150 million shares authorized,  68,189,314 and 48,682,118 shares outstanding in 2012 and 2011,respectively

681,893486,821Additional paid-in capital

114,884,91599,645,655Accumulated deficit

(108,594,175)(98,472,658)Total stockholders' equity6,972,6331,659,818Total liabilities and stockholders' equity$
4,086,177 Neuralstem, Inc.Statements of OperationsYear Ended December 31,20122011Revenues

390,625Operating expenses:Research and development costs

6,105,9847,354,857General and administrative expenses

4,247,0375,839,188Depreciation and amortization

211,143187,050Total operating expenses

10,564,16413,381,095Operating loss

(10,156,456)(12,990,470)Other income (expense):Litigation settlement

3,484250,000Interest income

34,15460,955Interest expense

(2,699)(821)Gain from change in fair value of warrant obligations

-161,809Total other income (expense) 

34,939471,943Net loss

(12,518,527)Net loss per share - basic and diluted

(0.26)Weighted average common shares outstanding - basic and diluted


About Neuralstem

Neuralstem's patented technology enables the ability to produce n

SOURCE Neuralstem, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Neuralstem ALS Stem Cell Trial Featured on Fox Atlanta
2. Neuralstem President and CEO to Update Ongoing ALS and NSI-189/Major Depressive Disorder Trials at 2012 Biotech Showcase
3. Neuralstem President and CEO to Present at BIO CEO & Investor Conference 2012
4. Neuralstem Announces Closing of $5.2-Million Registered Direct Offering
5. Fourteenth Patient Dosed in Neuralstem ALS Stem Cell Trial
6. Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London
7. Neuralstem Receives Notice Of Issuance For Patent Covering Human Neural Cell Transplantation For Neurodegenerative Conditions
8. Neuralstem President And CEO To Present At The 2012 Rodman & Renshaw Annual Healthcare Conference
9. Neuralstem Cells Induce Significant Functional Improvement In Permanent Rat Spinal Cord Injury, Cell Study Reports
10. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
11. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
Post Your Comments:
(Date:7/24/2014)... N.J. , July 24, 2014 ... provider of regulatory and ethical review services for ... Alliance Biosciences. Formerly a division of ... was the leading biosafety and biosecurity consulting firm ... With this addition, WCG,s biosafety division – WCG ...
(Date:7/24/2014)... 2014 The first part of the ... First in Human Studies” will cover comprehensive clinical support ... , With increasing R&D costs and declining industry success ... maximize the knowledge collected in early Phase I/IIa study ... in late stage development. , Next, the presenters will ...
(Date:7/24/2014)... Md. , July 24, 2014  Spherix Incorporated ... the fostering and monetization of intellectual property, today announced ... the period ending June 30, 2014 on Monday, August ... call at 10 a.m. ET on Monday, August 18, ... be led by the company,s CEO, Anthony Hayes ...
(Date:7/24/2014)... Bound Brook, NJ (PRWEB) July 24, 2014 ... expects to manage numerous projects in the MENA region ... delighted to have a preferred provider agreement with DZS ... in the MENA region,” said Global VP of R&D ... "DZS has developed excellent operational practices with a ...
Breaking Biology Technology:WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2Spherix Schedules Shareholder Update Call 2SBI Pharmaceuticals Co. Ltd. Enters into Preferred Provider Agreement with DZS Clinical Services 2
... integrated data that combines business and technology strategies, is ... murky technology concept it is a leading-edge business ... convergence allows companies to communicate more completely and at ... the bottom line. , ,In my own experience, ...
... help cell-phone users take advantage of the limitless minutes ... engineers have developed a device that can significantly improve ... battery power. , ,"When you've been talking on a ... how hot it gets," notes Zhenqiang "Jack" Ma, an ...
... laboratory" of teaching technology will use Mediasite Live, ... Foundry, Inc. , to automatically record, distribute, archive ... , ,The laboratory, termed the Digital Union, is ... making informed investment decisions across Ohio's flagship campus ...
Cached Biology Technology:WTN Visions: Convergence is changing business 2WTN Visions: Convergence is changing business 3UW-Madison technology to advance cell phones 2UW-Madison technology to advance cell phones 3Ohio State's educational tech lab to use Sonic Foundry system 2
(Date:7/24/2014)... NJIT this week for an all-day public forum on ... Agency (EPA) to dredge toxic sediment from an eight-mile ... has called the plan, which proposes removing 4.3 million ... the riverbed, one of the largest cleanups in the ... disposed off-site. , "We need to ensure the future ...
(Date:7/24/2014)... is currently conducting research into the potato genes that ... by a reduction in rainfall and increased extremes of ... most resistant genes in order to create new potato ... research is also seeking to find out how the ... greater drought and higher and lower temperatures. , This ...
(Date:7/24/2014)... successfully treated lupus in mice, a biomedical engineer at the ... his research to a new version of the drug in ... Chandra Mohan, Hugh Roy and Lillie Cranz Cullen Endowed Professor ... Arthritis Research & Therapy outlining the use of a new ... number of cases of lupus-related kidney disease., He now has ...
Breaking Biology News(10 mins):Experts Weigh the Pros and Cons of a $1.7 Billion EPA Cleanup Plan for the Passaic River at an NJIT 2Neiker-Tecnalia is researching the potato genes that best adapt to climate change 2Biomedical engineer looks at new applications for novel lupus drug 2Biomedical engineer looks at new applications for novel lupus drug 3
... states that when dinosaurs died and became fossilized, ... transformed into "rocks" through a gradual replacement of ... a North Carolina State University paleontologist, however, could ... Mary Schweitzer, assistant professor of paleontology with a ...
... may be in its infancy, but biologists may soon ... living cell like never before. Scientists at the U.S. ... and Lawrence Livermore National Laboratory have developed a way ... can track life's fundamental processes, such as DNA repair, ...
... has,found the first clear evidence that the process ... and respond to a million,different proteins might have ... function is to jump around in genetic material., ... genetic material, and scientists,have suspected that this ability ...
Cached Biology News:NC State scientist finds soft tissue in T. rex bones 2Nano-Probes Allow an Inside Look at Cell Nuclei 2Nano-Probes Allow an Inside Look at Cell Nuclei 3UCSD Discovery Shows How Embryonic Stem Cells Perform 'Quality Control' Inspections 2UCSD Discovery Shows How Embryonic Stem Cells Perform 'Quality Control' Inspections 3
Anti-MMP-14, catalytic domain, clone LEM-2/15.8 Immunogen: Synthetic peptide: amino acid sequence 218-233 within the catalytic domain Available Date: 38579...
Anti-MMP-14, catalytic domain, clone LEM-2/15.8 Immunogen: Synthetic peptide: amino acid sequence 218-233 within the catalytic domain Available Date: 38579...
Anti-MMP-19 (RASI), carboxy terminal region; rabbit host...
Rabbit anti MMP-13, Hinge Region MMP-13 Hinge Region...
Biology Products: